Pharma Deals Review, Vol 2002, No 25 (2002)

Font Size:  Small  Medium  Large

Degussa AG divests pharmaceutical interests

Business Review Editor

Abstract


Degussa divested its pharmaceutical business for around €6.5 B. Degussa had sold ASTA oncology business to Baxter International, Viatris GmbH to Advent International and also AWD.pharma. The company had planned to sell its MainGen GmbH to CRYO-CELL Europe.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.